3-(4-bromophenyl)-5-(((1-(p-tolyl)-1H-imidazol-2-yl)thio)methyl)-1,2,4-oxadiazole结构式
|
常用名 | 3-(4-bromophenyl)-5-(((1-(p-tolyl)-1H-imidazol-2-yl)thio)methyl)-1,2,4-oxadiazole | 英文名 | 3-(4-bromophenyl)-5-(((1-(p-tolyl)-1H-imidazol-2-yl)thio)methyl)-1,2,4-oxadiazole |
|---|---|---|---|---|
| CAS号 | 1112002-87-5 | 分子量 | 427.3 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C19H15BrN4OS | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 3-(4-bromophenyl)-5-(((1-(p-tolyl)-1H-imidazol-2-yl)thio)methyl)-1,2,4-oxadiazole |
|---|
| 分子式 | C19H15BrN4OS |
|---|---|
| 分子量 | 427.3 |
| InChIKey | XHKZBJACIVCPHY-UHFFFAOYSA-N |
| SMILES | Cc1ccc(-n2ccnc2SCc2nc(-c3ccc(Br)cc3)no2)cc1 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|